Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.
Pranke I, Bidou L, Martin N, Blanchet S, Hatton A, Karri S, Cornu D, Costes B, Chevalier B, Tondelier D, Girodon E, Coupet M, Edelman A, Fanen P, Namy O, Sermet-Gaudelus I, Hinzpeter A.
Pranke I, et al. Among authors: martin n.
ERJ Open Res. 2018 Feb 23;4(1):00080-2017. doi: 10.1183/23120541.00080-2017. eCollection 2018 Jan.
ERJ Open Res. 2018.
PMID: 29497617
Free PMC article.